Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis
Open Access
- 25 March 2007
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 254 (7) , 901-6
Abstract
The analysis of markers in the cerebrospinal fluid (CSF) is useful in the diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD). However, the time at which the study of these markers is most sensitive remains controversal.Keywords
This publication has 13 references indexed in Scilit:
- CSF tests in the differential diagnosis of Creutzfeldt-Jakob diseaseNeurology, 2006
- Diagnostic problems during late course in Creutzfeldt-Jakob diseaseJournal of Neurology, 2003
- Increased Detection of 14-3-3 Protein in Cerebrospinal Fluid in Sporadic Creutzfeldt-Jakob Disease during the Disease CourseEuropean Neurology, 2002
- Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob diseaseNeurology, 2002
- 14-3-3 Protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patientsAnnals of Neurology, 2001
- Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob diseaseNeurology, 2000
- A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluidJournal of Immunological Methods, 1997
- Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob diseaseThe Lancet, 1995
- High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob diseaseClinica Chimica Acta, 1992